Autologous Plasmin-Assisted Vitrectomy for Stage 5 Retinopathy of Prematurity: A Preliminary Trial - 21/08/11
, Shigeru Honda a, Hisanori Imai a, Naoshi Kondo a, Shigeki Fujii a, Naoki Yokoyama b, Akira Hirata c, Takahiro Kawaji d, Mikiko Fukushima d, Hidenobu Tanihara d, Akira Negi a
Inquiries to Yasutomo Tsukahara, Department of Organs Therapeutics, Division of Ophthalmology, Kobe University Graduate School of Medicine, 7-5-2 Kusunoki-cho, Chuo-ku, Kobe 650-0017, JapanRésumé |
Purpose |
To evaluate the efficacy of autologous plasmin (AP)-assisted vitrectomy for stage 5 retinopathy of prematurity (ROP).
Design |
Interventional case series.
Methods |
Six consecutive eyes of four children with stage 5 ROP were treated. The patients’ ages at the surgery ranged from five to eight months after birth. Four eyes showed closed-closed configuration and two eyes showed open-open configuration. After lensectomy and dissection of the anterior proliferative membrane, 0.03 to 0.22 International Unit (IU) of AP was administrated into the vitreous cavity. After 15 to 30 minutes of incubation, the proliferative membrane was treated.
Results |
The proliferative membrane was removed successfully without iatrogenic retinal break. Complete reattachment of the posterior pole retina was achieved in all six eyes (100%). No obvious complication was observed in the follow-up period, which ranged from 11 to 14 months.
Conclusions |
These results suggest the benefit of AP in the vitrectomy for treatment of stage 5 ROP.
Le texte complet de cet article est disponible en PDF.
Vol 144 - N° 1
P. 139-141 - juillet 2007 Retour au numéro
Article précédent
- Mist Delivery of Eye Medication to the Anterior Segment
- James F. Collins, Darlene A. Dartt, Reza Dana
- A Method for Noncontact Measurement of Corneal Diameter in Children
- Wolf A. Lagrèze, Gergely Zobor
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?